Riluzole for treatment of men with methamphetamine dependence: A randomized, double-blind, placebo-controlled clinical trial
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Riluzole for treatment of men with methamphetamine dependence: A randomized, double-blind, placebo-controlled clinical trial
Authors
Keywords
-
Journal
JOURNAL OF PSYCHOPHARMACOLOGY
Volume -, Issue -, Pages 026988111881716
Publisher
SAGE Publications
Online
2018-12-11
DOI
10.1177/0269881118817166
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Amphetamine maintenance differentially modulates effects of cocaine, methylenedioxypyrovalerone (MDPV), and methamphetamine on intracranial self-stimulation and nucleus accumbens dopamine in rats
- (2018) Amy R. Johnson et al. NEUROPSYCHOPHARMACOLOGY
- Pharmacotherapeutic agents in the treatment of methamphetamine dependence
- (2017) Kirsten C. Morley et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Brain-derived neurotrophic factor levels and depression during methamphetamine withdrawal
- (2017) Wenwei Ren et al. JOURNAL OF AFFECTIVE DISORDERS
- Consequences of brain-derived neurotrophic factor withdrawal in CNS neurons and implications in disease
- (2017) Abigail Mariga et al. NEUROBIOLOGY OF DISEASE
- A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Comparison Design Trial of Adjunctive Riluzole for Treatment-Resistant Major Depressive Disorder
- (2017) Sanjay J Mathew et al. NEUROPSYCHOPHARMACOLOGY
- Neuropsychological comparisons of cocaine versus methamphetamine users: A research synthesis and meta-analysis
- (2017) Matthew G. Hall et al. AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE
- Association of Stimulant Use With Dopaminergic Alterations in Users of Cocaine, Amphetamine, or Methamphetamine
- (2017) Abhishekh H. Ashok et al. JAMA Psychiatry
- Cellular and molecular mechanisms of the brain-derived neurotrophic factor in physiological and pathological conditions
- (2016) Veronica Begni et al. CLINICAL SCIENCE
- Riluzole combination therapy for moderate-to-severe major depressive disorder: A randomized, double-blind, placebo-controlled trial
- (2016) Elaheh Salardini et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Time-Dependent Serum Brain-Derived Neurotrophic Factor Decline During Methamphetamine Withdrawal
- (2016) Wenwei Ren et al. MEDICINE
- Riluzole in augmentation of fluvoxamine for moderate to severe obsessive-compulsive disorder: Randomized, double-blind, placebo-controlled study
- (2016) Sahra Emamzadehfard et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Riluzole Augmentation in Treatment-Refractory Obsessive-Compulsive Disorder
- (2015) Christopher Pittenger et al. JOURNAL OF CLINICAL PSYCHIATRY
- The Effects of BDNF Val66Met Gene Polymorphism on Serum BDNF and Cognitive Function in Methamphetamine-Dependent Patients and Normal Controls
- (2015) Hang Su et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- BDNF (Val66Met) genetic polymorphism is associated with vulnerability for methamphetamine dependence
- (2015) Sri-arun Iamjan et al. PHARMACOGENOMICS
- Riluzole Stimulates BDNF Release from Human Platelets
- (2015) Patrick Türck et al. Biomed Research International
- Sustained-release methylphenidate in methamphetamine dependence treatment: a double-blind and placebo-controlled trial
- (2015) Farzin Rezaei et al. DARU-Journal of Pharmaceutical Sciences
- The Global Burden of Mental, Neurological and Substance Use Disorders: An Analysis from the Global Burden of Disease Study 2010
- (2015) Harvey A. Whiteford et al. PLoS One
- Epidemiology of stimulant misuse and abuse: Implications for future epidemiologic and neuropharmacologic research
- (2014) Karen K. Gerlach et al. NEUROPHARMACOLOGY
- An association between BDNF Val66Met polymorphism and impulsivity in methamphetamine abusers
- (2014) Hang Su et al. NEUROSCIENCE LETTERS
- 12-Week, Placebo-Controlled Trial of Add-on Riluzole in the Treatment of Childhood-Onset Obsessive–Compulsive Disorder
- (2013) Paul J Grant et al. NEUROPSYCHOPHARMACOLOGY
- A double-blind, placebo controlled, randomized trial of riluzole as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia
- (2013) Mehdi Farokhnia et al. PSYCHOPHARMACOLOGY
- Riluzole as an Adjunctive Therapy to Risperidone for the Treatment of Irritability in Children with Autistic Disorder: A Double-Blind, Placebo-Controlled, Randomized Trial
- (2013) Ali Ghaleiha et al. PEDIATRIC DRUGS
- Serum brain-derived neurotrophic factor levels were reduced during methamphetamine early withdrawal
- (2012) Pao-Huan Chen et al. ADDICTION BIOLOGY
- Methamphetamine use: A comprehensive review of molecular, preclinical and clinical findings
- (2012) William J. Panenka et al. DRUG AND ALCOHOL DEPENDENCE
- A pilot study of hippocampal volume and N-acetylaspartate (NAA) as response biomarkers in riluzole-treated patients with GAD
- (2012) Chadi G. Abdallah et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Gender, Brain-Derived Neurotrophic Factor Val66Met, and Frequency of Methamphetamine Use
- (2012) Keith G. Heinzerling et al. Gender Medicine
- Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial
- (2012) Ali Ghaleiha et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial
- (2012) Mahtab Asadabadi et al. PSYCHOPHARMACOLOGY
- Antidepressant-like properties of oral riluzole and utility of incentive disengagement models of depression in mice
- (2011) Shannon L. Gourley et al. PSYCHOPHARMACOLOGY
- A double-blind, placebo-controlled study of N-acetyl cysteine plus naltrexone for methamphetamine dependence
- (2010) Jon E. Grant et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Review of the Use of the Glutamate Antagonist Riluzole in Psychiatric Disorders and a Description of Recent Use in Childhood Obsessive-Compulsive Disorder
- (2010) Paul Grant et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- Riluzole protects Huntington disease patients from brain glucose hypometabolism and grey matter volume loss and increases production of neurotrophins
- (2009) Ferdinando Squitieri et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Rapid Enhancement of Glutamatergic Neurotransmission in Bipolar Depression Following Treatment with Riluzole
- (2009) Brian P Brennan et al. NEUROPSYCHOPHARMACOLOGY
- Riluzole in the Treatment of Mood and Anxiety Disorders
- (2008) Christopher Pittenger et al. CNS DRUGS
- Riluzole in psychiatry: a systematic review of the literature
- (2008) Carlos A Zarate et al. Expert Opinion on Drug Metabolism & Toxicology
- Riluzole and d-amphetamine interactions in humans
- (2007) Mehmet Sofuoglu et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now